Rheumatic Diseases

Also known as: Rheumatic Disease

DrugDrug NameDrug Description
DB02266Flufenamic acidAn analgesic drug used to relieve pain associated with rheumatoid diseases.
DB00712FlurbiprofenAn NSAID used to treat the signs and symptoms of osteoarthritis and rheumatoid arthritis.
DB00281LidocaineA local anesthetic used in a wide variety of superficial and invasive procedures.
DrugDrug NameTargetType
DB02266Flufenamic acidAldo-keto reductase family 1 member C3target
DB02266Flufenamic acidTransthyretincarrier
DB02266Flufenamic acidProstaglandin G/H synthase 2target
DB02266Flufenamic acidProstaglandin G/H synthase 1target
DB02266Flufenamic acidSolute carrier family 22 member 6transporter
DB02266Flufenamic acidAndrogen receptortarget
DB02266Flufenamic acidPeroxisome proliferator-activated receptor alphatarget
DB02266Flufenamic acidPeroxisome proliferator-activated receptor gammatarget
DB00712FlurbiprofenProstaglandin G/H synthase 2target
DB00712FlurbiprofenProstaglandin G/H synthase 1target
DB00712FlurbiprofenCytochrome P450 2C9enzyme
DB00712FlurbiprofenSerum albumincarrier
DB00712FlurbiprofenMultidrug resistance-associated protein 4transporter
DB00712FlurbiprofenSolute carrier family 22 member 6transporter
DB00712FlurbiprofenUDP-glucuronosyltransferase 2B7enzyme
DB00712FlurbiprofenUDP-glucuronosyltransferase 1-1enzyme
DB00712FlurbiprofenUDP-glucuronosyltransferase 1-3enzyme
DB00712FlurbiprofenUDP-glucuronosyltransferase 1-9enzyme
DB00712FlurbiprofenUDP-glucuronosyltransferase 2B4enzyme
DB00281LidocaineSodium channel protein type 5 subunit alphatarget
DB00281LidocaineSodium channel protein type 10 subunit alphatarget
DB00281LidocaineEpidermal growth factor receptortarget
DB00281LidocaineSodium channel protein type 9 subunit alphatarget
DB00281LidocaineCytochrome P450 1A2enzyme
DB00281LidocaineCytochrome P450 2D6enzyme
DB00281LidocaineCytochrome P450 3A4enzyme
DB00281LidocaineCytochrome P450 3A5enzyme
DB00281LidocaineCytochrome P450 3A7enzyme
DB00281LidocaineSolute carrier family 22 member 5transporter
DB00281LidocaineP-glycoprotein 1transporter
DB00281LidocaineCytochrome P450 2A6enzyme
DB00281LidocaineCytochrome P450 2B6enzyme
DB00281LidocaineCytochrome P450 2C8enzyme
DB00281LidocaineCytochrome P450 2C9enzyme
DB00281LidocaineSodium channel protein type 4 subunit alphatarget
DB00281LidocaineAlpha-1-acid glycoprotein 1target
DB00281LidocaineAlpha-1-acid glycoprotein 2target
DrugDrug NamePhaseStatusCount
DB01234Dexamethasone1 / 2Unknown Status1
DB00295Morphine1 / 2Unknown Status1
DB11938Difelikefalin2Completed1
DB00924Cyclobenzaprine3Completed1
DB00924Cyclobenzaprine3Terminated1
DB15654Moderna COVID-19 Vaccine3Active Not Recruiting1
DB06228Rivaroxaban3Completed1
DB01281Abatacept4Active Not Recruiting1
DB00316Acetaminophen4Completed1
DB15806CoronaVac4Active Not Recruiting1
DB00741Hydrocortisone4Completed1
DB14444Influenza A virus A/California/7/2009 (H1N1)-like antigen (propiolactone inactivated)4Completed1
DB00563Methotrexate4Active Not Recruiting1
DB00316AcetaminophenNot AvailableCompleted1
DB00193TramadolNot AvailableCompleted1